Document Detail

Cost-effectiveness of alternative approaches to the management of chronic obstructive coronary artery disease.
MedLine Citation:
PMID:  19898279     Owner:  NLM     Status:  MEDLINE    
Chronic obstructive coronary artery disease (CAD) is a highly prevalent condition that results in premature mortality as well as substantial morbidity due to angina and reduced quality of life. Various treatment and revascularization strategies are available for managing this condition, including medical therapy, percutaneous coronary intervention, and coronary artery bypass grafting. These treatments are expensive and, given the high prevalence of chronic CAD, there is substantial cost involved in the management of this condition. Recent clinical trials comparing percutaneous coronary intervention with medical management and/or coronary artery bypass grafting, and their associated economic analyses, have generated new information regarding the relative value of these alternative treatment strategies. In this article, we review the basic concepts of cost-effectiveness analysis and the current evidence as it relates to the cost-effectiveness of percutaneous coronary intervention in the management of chronic obstructive coronary artery disease.
Amit P Amin; David J Cohen
Related Documents :
8605639 - Coronary artery disease following repair of tetralogy of fallot: implications and manag...
12748209 - Congenital coronary artery dilatation.
12844109 - External iliac artery endofibrosis: a new possible predisposing factor.
16132279 - Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial a...
17977779 - Disappearance of resting tremor after thalamic stroke involving the territory of the tu...
9689799 - Long-term treatment with cyclosporin a and coumarin in pulmonary thromboembolic behçet...
11565659 - Off-pump bypass grafting is safe in patients with left main coronary disease.
2971789 - Causes of false-negative auscultation of regurgitant lesions: a doppler echocardiograph...
15305559 - Orbital cavernous hemangioma associated with juxtapapillary exophytic retinal capillary...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Reviews in cardiovascular medicine     Volume:  10 Suppl 2     ISSN:  1530-6550     ISO Abbreviation:  Rev Cardiovasc Med     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-09     Completed Date:  2010-11-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960007     Medline TA:  Rev Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S3-13     Citation Subset:  IM    
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon, Coronary / economics*
Cardiovascular Agents / economics*,  therapeutic use*
Chronic Disease
Coronary Artery Bypass / economics*
Coronary Artery Disease / economics*,  therapy*
Cost-Benefit Analysis
Drug Costs
Evidence-Based Medicine
Health Care Costs*
Hospital Costs
Treatment Outcome
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of left main and multivessel disease in the drug-eluting stent era.
Next Document:  Interpreting the results of the COURAGE trial: a non-interventionalist perspective.